Entresto cost in 2026, and the end of its negotiated price
Medicare pays $295 for 30 days of Entresto in 2026; a pharmacy pays about $695 for 60 tablets.
Entresto (sacubitril and valsartan), Novartis’s twice-daily heart failure tablet, has a Medicare negotiated price of $295 for a 30-day supply in 2026, against a 2023 list price of $628. On the standard Part D benefit, a year at that price costs about $1,346. The CMS file does not carry a negotiated price for 2027: the 2027 line is dated to end on December 31, 2026, so Part D plans return to their own contracted prices and the calculator falls back to the pharmacy acquisition cost for 2027. Without insurance, there is no Novartis or TrumpRx self-pay offer for the brand; pharmacies pay about $695 for 60 tablets according to the NADAC survey of October 14, 2026. TrumpRx does list generic sacubitril-valsartan, which a pharmacist can substitute only when the prescription allows.
The whole of 2026, by way of paying
- Paying cash (self-pay)no published price
- Medicare Part D, covered use$1,346
- Medicaid, at a $4.00 copay$48
You would pay, Entresto 97/103 mg twice a day
$112 / month
$1,346 in 2026
Standard 2026 Part D benefit: deductible, then 25% of the cost, below the yearly cap.
Same dose, other ways to pay (per month)
- List price (wholesale acquisition cost)not published
- What pharmacies pay (NADAC)$695
- Medicare negotiated price, 2026$295
- Medicare Part D, your share (month avg., 2026)$112
TrumpRx and makers read on October 16, 2026 · NADAC file of October 14, 2026. Estimate only, not medical advice. How it is calculated
Prices read by Radif Partners · Editorial policy · Method and data
Two tablets a day, one monthly price
| Tablet | NADAC per tablet | Pharmacy cost, 60 tablets | Medicare 2026, 30 days |
|---|---|---|---|
| 24/26 mg twice a day | $11.59 | $696 | $295 |
| 49/51 mg twice a day | $11.56 | $694 | $295 |
| 97/103 mg twice a day | $11.59 | $695 | $295 |
All three strengths cost a pharmacy the same per tablet, and the label’s twice-daily dosing makes 60 tablets a month. Medicare’s negotiated price is likewise one figure for any 30-day supply.
Why the 2027 price is missing
A negotiated price stops applying when a drug no longer qualifies, for example once a generic version is marketed. CMS’s published file shows Entresto’s 2027 inflation-adjusted line closed before it opens, and no other 2027 price. For a Part D enrollee this means the 25% coinsurance will again be computed on the plan’s price, which may be higher or lower than $295. We will update the page if CMS publishes a different entry.
Heart failure drugs and the cap
Heart failure treatment often combines several brand drugs, Entresto with Farxiga or Jardiance among them. The cap of $2,100 in 2026 and $2,400 in 2027 applies to all covered drugs together; the cap calculator adds them up and the payment plan guide explains how to spread the bill.